Dipna Pharmachem Ltd

Dipna Pharmachem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dipna Pharmachem Ltd

₹ 17.4 4.56%
17 Apr - close price
dipnapharmachem.com BSE - SME: 543594
About

Incorporated in 2011, Dipna Pharmachem Ltd
is in the business of Pharmaceutical Trading[1]

Key Points

Business Overview:[1]
DPL is a trader, importer, and exporter of industrial Chemical and Pharmaceutical Raw materials, APIs, Solvents, Excipients, Intermediates, and Formulations. It provides assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark parameters of certificates like WHO-GMP

Website BSE
  • Market Cap ₹ 41.9 Cr.
  • Current Price ₹ 17.4
  • High / Low ₹ 18.1 / 6.40
  • Stock P/E 50.5
  • Book Value ₹ 15.8
  • Dividend Yield 0.00 %
  • ROCE 7.05 %
  • ROE 3.52 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 1.11 times its book value
  • Debtor days have improved from 103 to 68.7 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 9.98%
  • Company has a low return on equity of 7.02% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024
29 44 49 74 74 90 91
28 42 48 73 73 88 89
Operating Profit 1 1 1 2 2 2 1
OPM % 3% 3% 2% 2% 2% 2% 2%
0 0 0 0 0 0 0
Interest 0 0 0 1 1 1 1
Depreciation 0 0 0 0 0 0 0
Profit before tax 0 1 0 1 1 1 0
Tax % 25% 26% 26% 27% 27% 21% 26%
0 1 0 1 1 0 0
EPS in Rs 33.00 84.00 0.13 0.24 0.24 0.20 0.14
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
17 20 30 31 73 100 164 181
16 20 30 31 71 98 161 178
Operating Profit 0 0 0 0 2 2 3 3
OPM % 2% 2% 1% 1% 3% 2% 2% 2%
0 0 0 0 0 0 0 0
Interest 0 0 0 0 1 1 2 2
Depreciation 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 0 2 1 1 1
Tax % 14% 40% 0% 60% 26% 34% 24%
0 0 0 0 1 1 1 1
EPS in Rs 6.00 3.00 6.00 2.00 117.00 0.37 0.45 0.34
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 52%
3 Years: 74%
TTM: 22%
Compounded Profit Growth
10 Years: %
5 Years: 105%
3 Years: 279%
TTM: -30%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 113%
Return on Equity
10 Years: %
5 Years: 7%
3 Years: 7%
Last Year: 4%

Balance Sheet

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.04 0.04 0.04 0.04 0.04 12 24 24
Reserves 0 0 1 1 2 12 13 14
5 6 10 12 10 16 19 17
6 8 8 12 24 37 76 78
Total Liabilities 11 14 18 25 36 78 133 133
0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0
11 14 18 25 36 78 133 133
Total Assets 11 14 18 25 36 78 133 133

Cash Flows

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-3 -2 3 -21 -5
0 0 -0 -0 -0
3 2 -3 26 14
Net Cash Flow 0 0 -0 5 8

Ratios

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 132 160 134 176 135 104 69
Inventory Days 112 66 70 89 34 72 86
Days Payable 142 148 105 145 123 139 172
Cash Conversion Cycle 103 78 99 120 46 38 -17
Working Capital Days 116 114 119 150 59 126 96
ROCE % 8% 5% 3% 17% 9% 7%

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024
66.56% 66.56% 57.19% 9.98% 9.98%
33.45% 33.43% 42.81% 90.02% 90.02%
No. of Shareholders 1,1109921,0781,8072,652

Documents

Announcements

Annual reports